Acucela aims to raise $125M going public on Tokyo exchange
HONG KONG – Looking to Japan for new funds, an embattled Seattle-based drug developer plans to issue shares on the Tokyo Stock Exchange in the hopes of raising as much as $125 million to develop ophthalmic treatments.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter